A Phase II, Open-Label, Non-Randomized Trial of Sunitinib in Certain Subtypes of Soft Tissue Sarcomas.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 05 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Mar 2009 New trial record